These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins. Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966 [TBL] [Abstract][Full Text] [Related]
5. Monosubstituted Coumarins Inhibit Epinephrine-induced Platelet Aggregation. Jiménez-Orozco FA; Galicia-Zapatero S; López-López E; Medina-Franco JL; Cedeño FL; Flores-García M; Mejia-Domínguez AM; de la Peña-Díaz A Cardiovasc Hematol Agents Med Chem; 2022; 20(1):43-51. PubMed ID: 33906594 [TBL] [Abstract][Full Text] [Related]
6. Novel compounds of hybrid structure pyridazinone-coumarin as potent inhibitors of platelet aggregation. Costas-Lago MC; Besada P; Cano E; Terán C Future Med Chem; 2019 Aug; 11(16):2051-2062. PubMed ID: 31538518 [No Abstract] [Full Text] [Related]
7. Studies on the antiplatelet and antithrombotic profile of anti-inflammatory coumarin derivatives. Kontogiorgis C; Nicolotti O; Mangiatordi GF; Tognolini M; Karalaki F; Giorgio C; Patsilinakos A; Carotti A; Hadjipavlou-Litina D; Barocelli E J Enzyme Inhib Med Chem; 2015 Dec; 30(6):925-33. PubMed ID: 25807297 [TBL] [Abstract][Full Text] [Related]
8. Antiplatelet activity of deferiprone through cyclooxygenase-1 inhibition. Tran NT; Akkawat B; Morales NP; Rojnuckarin P; Luechapudiporn R Platelets; 2020 May; 31(4):505-512. PubMed ID: 31366263 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors. Vitale P; Tacconelli S; Perrone MG; Malerba P; Simone L; Scilimati A; Lavecchia A; Dovizio M; Marcantoni E; Bruno A; Patrignani P J Med Chem; 2013 Jun; 56(11):4277-99. PubMed ID: 23651359 [TBL] [Abstract][Full Text] [Related]
10. Substrate specificity of acetoxy derivatives of coumarins and quinolones towards Calreticulin mediated transacetylation: investigations on antiplatelet function. Kathuria A; Priya N; Chand K; Singh P; Gupta A; Jalal S; Gupta S; Raj HG; Sharma SK Bioorg Med Chem; 2012 Feb; 20(4):1624-38. PubMed ID: 22264757 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity. Jin YR; Han XH; Zhang YH; Lee JJ; Lim Y; Chung JH; Yun YP Atherosclerosis; 2007 Sep; 194(1):144-52. PubMed ID: 17092506 [TBL] [Abstract][Full Text] [Related]
12. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization. Chang MC; Uang BJ; Tsai CY; Wu HL; Lin BR; Lee CS; Chen YJ; Chang CH; Tsai YL; Kao CJ; Jeng JH Br J Pharmacol; 2007 Sep; 152(1):73-82. PubMed ID: 17641677 [TBL] [Abstract][Full Text] [Related]
13. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553 [TBL] [Abstract][Full Text] [Related]
15. Antiplatelet actions of some coumarin compounds isolated from plant sources. Teng CM; Li HL; Wu TS; Huang SC; Huang TF Thromb Res; 1992 Jun; 66(5):549-57. PubMed ID: 1523611 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory Mechanisms of Lusianthridin on Human Platelet Aggregation. Swe HN; Sritularak B; Rojnuckarin P; Luechapudiporn R Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202163 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of the biosynthesis of prostanoids and hydroxyeicosatetraenoic acids in human whole blood and platelets by targeted chiral lipidomics analysis. Tacconelli S; Fullone R; Dovizio M; Pizzicoli G; Marschler S; Bruno A; Zucchelli M; Contursi A; Ballerini P; Patrignani P Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158804. PubMed ID: 32853794 [TBL] [Abstract][Full Text] [Related]
18. Panax quinquefolium saponin combined with dual antiplatelet drugs inhibits platelet adhesion to injured HUVECs via PI3K/AKT and COX pathways. Wang MM; Xue M; Miao Y; Kou N; Xu YG; Yang L; Zhang Y; Shi DZ J Ethnopharmacol; 2016 Nov; 192():10-19. PubMed ID: 27401285 [TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of platelet lipoxygenase by esculetin. Sekiya K; Okuda H; Arichi S Biochim Biophys Acta; 1982 Oct; 713(1):68-72. PubMed ID: 6814494 [TBL] [Abstract][Full Text] [Related]
20. Antiplatelet action of 3',4'-diisovalerylkhellactone diester purified from Peucedanum japonicum Thunb. Hsiao G; Ko FN; Jong TT; Teng CM Biol Pharm Bull; 1998 Jul; 21(7):688-92. PubMed ID: 9703250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]